Galectin Therapeutics Inc. - stock earnings
GALT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -10.4 million USD | ? USD |
| 2023Q2 | -9.1 million USD | ? USD |
| 2023Q1 | -12.3 million USD | ? USD |
| 2022Q4 | -30.2 million USD | ? USD |
| 2022Q3 | -9.1 million USD | ? USD |
| 2022Q2 | -9.6 million USD | ? USD |
| 2022Q1 | -9.9 million USD | ? USD |
| 2021Q4 | -7.2 million USD | ? USD |
| 2021Q3 | -8.5 million USD | ? USD |
| 2021Q2 | -8.4 million USD | ? USD |
| 2021Q1 | -6.3 million USD | ? USD |
| 2020Q4 | -7.9 million USD | ? USD |
| 2020Q3 | -5.9 million USD | ? USD |
| 2020Q2 | -6.1 million USD | ? USD |
| 2020Q1 | -3.6 million USD | ? USD |
| 2019Q4 | -5.1 million USD | ? USD |
| 2019Q3 | -2.8 million USD | ? USD |
| 2019Q2 | -3.0 million USD | ? USD |
| 2019Q1 | -2.4 million USD | ? USD |
| 2018Q4 | -3.1 million USD | 19000 USD |
| 2018Q3 | -2.8 million USD | ? USD |
| 2018Q2 | -3.8 million USD | ? USD |
| 2018Q1 | -4.3 million USD | ? USD |
| 2017Q4 | -2.4 million USD | ? USD |
| 2017Q3 | -4.4 million USD | ? USD |
| 2017Q2 | -4.5 million USD | ? USD |
| 2017Q1 | -4.9 million USD | ? USD |
| 2016Q4 | -4.6 million USD | ? USD |
| 2016Q3 | -4.5 million USD | ? USD |
| 2016Q2 | -5.5 million USD | ? USD |
| 2016Q1 | -6.8 million USD | ? USD |
| 2015Q4 | -4.7 million USD | ? USD |
| 2015Q3 | -5.9 million USD | ? USD |
| 2015Q2 | -4.6 million USD | ? USD |
| 2015Q1 | -4.8 million USD | ? USD |
| 2014Q4 | -3.7 million USD | ? USD |
| 2014Q3 | -3.5 million USD | ? USD |
| 2014Q2 | -3.4 million USD | ? USD |
| 2014Q1 | -5.1 million USD | ? USD |
| 2013Q4 | -2.8 million USD | ? USD |
| 2013Q3 | -3.5 million USD | ? USD |
| 2013Q2 | -2.5 million USD | ? USD |
| 2013Q1 | -3.2 million USD | ? USD |
| 2012Q4 | -2.4 million USD | ? USD |
| 2012Q3 | -2.7 million USD | ? USD |
| 2012Q2 | -2.7 million USD | ? USD |
| 2012Q1 | -2.0 million USD | ? USD |
| 2011Q4 | -3.4 million USD | ? USD |
| 2011Q3 | -2.0 million USD | ? USD |
| 2011Q2 | -3.1 million USD | ? USD |
| 2011Q1 | -2.4 million USD | ? USD |
| 2010Q4 | -728000 USD | ? USD |
| 2010Q3 | -1.1 million USD | ? USD |
| 2010Q2 | -1.7 million USD | ? USD |
| 2010Q1 | -2.1 million USD | ? USD |
| 2009Q4 | -655000 USD | ? USD |
| 2009Q3 | -1.4 million USD | ? USD |
| 2009Q2 | -2.8 million USD | ? USD |
| 2009Q1 | -2.6 million USD | ? USD |
| 2008Q4 | -816000 USD | 2.2 million USD |
| 2008Q3 | 214000 USD | ? USD |
| 2008Q2 | -563000 USD | ? USD |
| 2008Q1 | -2.0 million USD | ? USD |
| 2007Q4 | -1.3 million USD | -3.0 million USD |
| 2007Q3 | -2.6 million USD | ? USD |
| 2007Q2 | 36000 USD | ? USD |
| 2007Q1 | 4.6 million USD | 4.1 million USD |
| 2006Q4 | 4.6 million USD | ? USD |
| 2006Q3 | 720000 USD | ? USD |
| 2006Q2 | -1.2 million USD | ? USD |
| 2006Q1 | -7.3 million USD | ? USD |
| 2005Q4 | -1.7 million USD | ? USD |
| 2005Q3 | -1.7 million USD | ? USD |
| 2005Q2 | -1.7 million USD | ? USD |
| 2005Q1 | -2.2 million USD | 69000 USD |
| 2004Q4 | -2.2 million USD | ? USD |
| 2004Q3 | -1.8 million USD | ? USD |
| 2004Q2 | -1.4 million USD | ? USD |
| 2004Q1 | -1.9 million USD | ? USD |
| 2003Q4 | -1.6 million USD | 68925 USD |
| 2003Q3 | -1.4 million USD | ? USD |
| 2003Q2 | -974608 USD | ? USD |
| 2003Q1 | -944866 USD | ? USD |
| 2002Q4 | -1.1 million USD | ? USD |
| 2002Q3 | -663560 USD | ? USD |
| 2002Q2 | -942410 USD | ? USD |
| 2002Q1 | -2.5 million USD | ? USD |
| 2001Q4 | -2.5 million USD | ? USD |
| 2001Q3 | -686291 USD | ? USD |
| 2001Q2 | -598143 USD | ? USD |
| 2001Q1 | -220000 USD | ? USD |
GALT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -41.7 million USD | ? USD |
| 2022 | -39.2 million USD | ? USD |
| 2021 | -31.0 million USD | ? USD |
| 2020 | -23.5 million USD | ? USD |
| 2019 | -13.4 million USD | ? USD |
| 2018 | -13.9 million USD | ? USD |
| 2017 | -16.2 million USD | ? USD |
| 2016 | -21.4 million USD | ? USD |
| 2015 | -20.0 million USD | ? USD |
| 2014 | -15.8 million USD | ? USD |
| 2013 | -12.1 million USD | ? USD |
| 2012 | -9.7 million USD | ? USD |
| 2011 | -10.9 million USD | ? USD |
| 2010 | -5.6 million USD | ? USD |
| 2009 | -7.5 million USD | ? USD |
| 2008 | -3.2 million USD | ? USD |
| 2007 | -9.4 million USD | ? USD |
| 2006 | -3.2 million USD | ? USD |
| 2005 | -6.5 million USD | ? USD |
| 2004 | -7.2 million USD | ? USD |
| 2003 | -4.9 million USD | ? USD |
| 2002 | -3.7 million USD | ? USD |
| 2001 | -4.0 million USD | ? USD |
| 2000 | -190000 USD | ? USD |
GALT
Price: $3.37
52 week price:
Earnings Per Share: -0.74 USD
P/E Ratio: -2.28
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 205300
Ebitda: -4.4 millionMarket Capitalization: 238.9 million